FDA tentatively approves first drug for muscular dystrophy

WASHINGTON (AP) — Federal health regulators have granted tentative approval to a highly contested drug for muscular dystrophy that has become a flashpoint in the debate over patient access to experimental medicine. The Food and Drug Administration said it cleared Sarepta Therapeutics’ injection for a rare form of Duchenne muscular dystrophy, a deadly inherited disease […]